Table of contents
- What was the background?
- Approval thresholds
- What are American Depositary Receipts (ADR)?
- Could the Depositary and other nominees appoint multiple proxies?
- How should the votes be counted for the headcount test?
- Did the exclusion of the Depositary from a currency election facility create a separate class?
- What are the practical implications of this case?
- Public company takeovers quiz
- Case details
Article summary
Corporate analysis: In Re GW Pharmaceuticals plc the High Court clarified how shares held by certain nominee shareholders, including the depositary under an American Depositary Receipt programme, should be treated for the purposes of the headcount test in Part 26 of the Companies Act 2006 (CA 2006). It also clarified that excluding the depositary from a currency election facility did not by itself result in the creation of a separate class of shareholders and that a single meeting of members could be held.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial